SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-016469
Filing Date
2024-02-16
Accepted
2024-02-16 16:44:29
Documents
1
Period of Report
2024-02-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3997
  Complete submission text file 0000950170-24-016469.txt   5430
Mailing Address 195 CHURCH STREET, FLOOR 14, NEW HAVEN CT 06510
Business Address
Galletta Christopher (Reporting) CIK: 0001486099 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38886 | Film No.: 24649076

Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)